Growth Metrics

Sanofi (SNY) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $10.0 billion.

  • Sanofi's Long-Term Deferred Tax rose 1770.72% to $10.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.0 billion, marking a year-over-year increase of 1770.72%. This contributed to the annual value of $9.7 billion for FY2025, which is 1281.38% up from last year.
  • Latest data reveals that Sanofi reported Long-Term Deferred Tax of $10.0 billion as of Q4 2025, which was up 1770.72% from $9.1 billion recorded in Q2 2025.
  • In the past 5 years, Sanofi's Long-Term Deferred Tax registered a high of $10.0 billion during Q4 2025, and its lowest value of $5.1 billion during Q2 2021.
  • Over the past 5 years, Sanofi's median Long-Term Deferred Tax value was $6.7 billion (recorded in 2023), while the average stood at $7.0 billion.
  • Per our database at Business Quant, Sanofi's Long-Term Deferred Tax plummeted by 402.14% in 2021 and then skyrocketed by 2724.25% in 2023.
  • Sanofi's Long-Term Deferred Tax (Quarter) stood at $5.3 billion in 2021, then increased by 4.37% to $5.5 billion in 2022, then increased by 25.96% to $6.9 billion in 2023, then increased by 23.12% to $8.5 billion in 2024, then grew by 17.71% to $10.0 billion in 2025.
  • Its last three reported values are $10.0 billion in Q4 2025, $9.1 billion for Q2 2025, and $8.5 billion during Q4 2024.